Sudden cardiac death (SCD) is a sudden, unexpected death caused by a change in heart rhythm. In the United States, it is the largest cause of natural death, causing about 325,000 adult deaths in the country each year. SCD is responsible for half of all heart disease deaths. Lack of readily available medical assistance is responsible for this high mortality rate.
Element Science, a San Francisco-based healthcare company, wants to change that with their new product, the Jewel Patch Wearable Cardioverter Defibrillator (P-WCD). This low-profile defibrillator is designed to detect and treat life-threatening arrhythmias. The device is also easy to use and discreet.
The Jewel P-WCD is the first product to be built on Element’s novel Jewel platform, which unites patient-centric human factor engineering and sophisticated machine learning algorithm development principles upon a foundation of rigorous electromechanical medical device development standards, reports Business Wire.
“Our next-generation digital wearable is a unique breakthrough in personalized digital healthcare based on years of extensive research and testing. The Jewel platform supports both therapeutic and diagnostic capabilities and is designed for ease of wearability to facilitate high compliance and efficacy,” said Dr. Kumar, Founder, President and CEO. “Given the broad potential for the Jewel platform to save and improve the lives of patients worldwide, we welcome the strong support of this impressive consortium of investors.”
The Jewel P-WCD has the potential to be easily adapted to a variety of clinical settings and care delivery models. “We see massive opportunities to significantly impact patient health with the proprietary Jewel platform in the US and Europe, as well as large, underserved markets such as China,” said Christopher Shen, MD, Managing Partner, Qiming Venture Partners USA. “We are excited to partner with Element Science in leading the effort to make this important life-saving technology available for patients globally.”
Last week, Element Science announced that it raised $145.6 million in Series C financing round, led by Deerfield Healthcare and Qiming Venture Partners USA.
Element Science is a medical device and digital health company focused on developing clinical-grade wearables, machine learning algorithms, and lifesaving therapies. The company has been led since its inception by Uday N. Kumar, MD, a cardiac electrophysiologist, who serves as faculty at Stanford University’s Byers Center for Biodesign and was a former Entrepreneur-in-Residence at Third Rock Ventures as well as the Founder of iRhythm Technologies.